Edap Tms S.a. (EDAP)
Edap Tms S.a. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Edap Tms S.a. (EDAP) is a Medical - Devices company based in FR with a market capitalization of $162.5M. Revenue grew 10.3% year-over-year and free cash flow was negative at -$22.2M. This page tracks EDAP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
FR · 310 employees · IPO Aug 1, 1997
Valuation
Valuation & price
$4.35 · as of May 26, 2026 · -15.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
8.37
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$162.5M
Market cap
10.3%
Revenue growth (YoY)
42.5%
Gross margin
-$22.2M
Free cash flow (USD)
$10.3M
Net debt
0.4%
Share dilution
0/6
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Edap Tms S.a.'s market cap?
Edap Tms S.a. (EDAP) has a market capitalization of $162.5M.
What is EDAP's P/E ratio?
A meaningful P/E ratio is not available for EDAP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is EDAP's price-to-book (P/B) ratio?
EDAP trades at 8.37 times book value per share.
Are insiders buying EDAP stock?
SEC Form 4 filings show no open-market insider buys at Edap Tms S.a. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.